Also trades as: VIMTALABS.BO (BSE) · $vol 0M

₹582.05 ($6.05)

-2.30 (-0.39%)

NSE · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 41 · ₹26.4B mcap · 14M float · 2.71% daily turnover

Analysis Technicals Weather Peers

Revenue

$4.1B +18.4% ▲

5Y CAGR: +14.3%

Gross Profit

$1.6B +19.3% ▲

5Y CAGR: +1.4%

Operating Income

$993M +13.1% ▲

5Y CAGR: +22.4%

Net Income

$775M +15.1% ▲

5Y CAGR: +29.4%

EPS (Diluted)

$17.20 +15.2% ▲

5Y CAGR: +28.9%

EBITDA

$1.4B +13.4% ▲

5Y CAGR: +21.8%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$2.8B	$3.2B	$3.2B	$3.4B	$4.1B
YoY Growth	+32.3%	+14.2%	+1.0%	+8.1%	+18.4%
Cost of Revenue	$1.8B	$739M	$763M	$2.1B	$2.5B
Gross Profit	$914M	$2.4B	$2.4B	$1.3B	$1.6B
Gross Margin	33.1%	76.6%	76.0%	38.5%	38.9%
R&D Expenses	$0	$0	$0	$0	$10M
SG&A Expenses	$89M	$115M	$110M	$1.0B	$105M
Operating Expenses	$361M	$1.7B	$1.8B	$448M	$589M
Operating Income	$553M	$697M	$619M	$878M	$993M
Operating Margin	20.0%	22.1%	19.5%	25.5%	24.4%
Interest Expense	$13M	$14M	$15M	$19M	$12M
Income Before Tax	$557M	$650M	$625M	$890M	$1.0B
Tax Expense	$144M	$168M	$137M	$222M	$264M
Net Income	$413M	$482M	$410M	$673M	$775M
Net Margin	15.0%	15.3%	12.9%	19.6%	19.0%
EPS (Diluted)	$9.16	$10.68	$9.12	$14.93	$17.20
EBITDA	$803M	$966M	$902M	$1.3B	$1.4B
Shares Outstanding	23M	23M	22M	22M	45M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$749M	$847M	$899M	$944M	$976M	$1.0B	$986M	$1.1B
Cost of Revenue	$1.2B	$183M	$206M	$547M	$565M	$201M	$587M	$648M
Gross Profit	$302M	$664M	$693M	$398M	$411M	$817M	$399M	$444M
Gross Margin	40.3%	78.3%	77.1%	42.1%	42.1%	80.2%	40.5%	40.7%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$245M	$0	$0	$316M	$172M	$0	$0	$178M
Operating Expenses	$122M	$448M	$460M	$160M	$172M	$577M	$166M	$178M
Operating Income	$179M	$216M	$233M	$238M	$238M	$240M	$233M	$266M
Operating Margin	24.0%	25.5%	25.9%	25.2%	24.4%	23.6%	23.6%	24.4%
Interest Expense	$5M	$4M	$6M	$4M	$3M	$4M	$2M	$3M
Income Before Tax	$182M	$219M	$239M	$250M	$253M	$263M	$234M	$290M
Tax Expense	$42M	$49M	$64M	$67M	$64M	$64M	$58M	$79M
Net Income	$123M	$170M	$215M	$183M	$189M	$199M	$176M	$211M
Net Margin	16.4%	20.1%	23.9%	19.4%	19.4%	19.6%	17.8%	19.3%
EPS (Diluted)	$2.73	$3.38	$4.78	$4.04	$4.21	$4.44	$3.94	$4.62
EBITDA	$252M	$306M	$343M	$347M	$354M	$369M	$344M	$421M
Shares Outstanding	22M	25M	22M	22M	45M	45M	45M	46M

VIMTALABS.NS NSE